Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Truvada and Descovy are both highly effective and generally safe options for HIV prevention.
“And So It Happened” profiles people taking HIV treatment and PrEP.
Researchers found that drawing out the delivery of the vaccine over a number of days yielded a stronger immune response.
A machine learning algorithm designed small sets of proteins that boasted the greatest potential to elicit a broad-based immune response.
But health officials stress there is still room for improvement.
If Black women had white women’s lower HIV rate, 93% of their annual new infections would be averted.
The Truvada manufacturer’s agreement with the Trump Administration is “a tremendous step toward ending the epidemic.”
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
Researchers surveyed PrEP-prescribing physicians in Western New York.
Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.
Researchers in an ongoing study are analyzing condom use among men who have sex with men in Chicago.
New HIV cases in the city remain higher than those in Los Angeles County and the state.
Researchers broke down the various strategies that the gay men in the Opposites Attract study used to prevent HIV transmission.
Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.
Canadian scientists found that using a lighter to heat an opioid drug in a cooker for 10 seconds cuts HIV risk when sharing cookers.
Murray Penner describes his journey to becoming Prevention Access Campaign’s U=U Executive Director, North America
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.